Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Administration of dendritic cells in cancer nodules in hepatocellular carcinoma.

Oncology reports - 1 Oct 2005

Kumagi Teru, Akbar S M Fazle, Horiike Norio, Kurose Kiyotaka, Hirooka Masashi, Hiraoka Atsushi, Hiasa Yoichi, Michitaka Kojiro, Onji Morikazu

Abstract excerpt

Dendritic cells (DCs), the most potent antigen-presenting cells in vivo, are now used for cancer immunotherapy during which they are usually administered to the blood of patients with cancer. However, the route of administration of DCs affects the magnitude of immune responses. This study was conducted to assess the safety of the direct administration of DCs into cancer nodules. DCs were generated by culturing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen Presentation
Share to B7-2 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer Vaccines

Share to Ethanol

Share to Granulocyte-Macrophage Colony-Stimulating Factor

Share to Immunotherapy, Adoptive

Share to Interleukin-4

Share to Ultrasonography

Source

Identifiers

PMID: 16142359

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Administration of dendritic cells in cancer nodules in hepatocellular carcinoma.PMID 16142359Read ↗

A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer.Semantic proximity Read ↗

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial.Semantic proximity Read ↗

CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.Semantic proximity Read ↗

In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.Semantic proximity Read ↗

Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.Semantic proximity Read ↗

Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma.Semantic proximity Read ↗

Ultrasound-mediated delivery of miRNA-122 and anti-miRNA-21 therapeutically immunomodulates murine hepatocellular carcinoma in vivoSemantic proximity Read ↗

Macrophages, but not dendritic cells, accumulate colloidal carbon following administration in situ.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.